Moreover, the number of IL-10+CD19+CD24+CD38+PDL1+ Bregs correlates with the Tregs proliferation ratio and with the inhibition of PD-1-positive effector T cells in patients with invasive BC. This evidence concerns the gene CD19 and breast cancer.